Press

News, Optichannel excellence

PharmaForceIQ Acquires Aktana to Deliver Unparalleled Cross-Functional Engagement Impact for Pharma

HCP engagement, Optichannel excellence

Maximizing ROI with Optichannel Marketing

Uncover why traditional omnichannel approaches often fall short in pharma and how optichannel marketing leverages data and precise targeting to deliver smarter engagement, minimize waste, and generate measurable ROI..

Launch planning, Optichannel excellence, Understanding ROI

Before and after optichannel: Rescuing a stalled launch in 5 months

See how we helped a brand team turn around a lackluster launch. Affinity intelligence and optichannel precision drove rapid adoption, growing market share in just a few months.

Customer journeys, HCP engagement, Media efficiency

Small budget, big lift: Hyper-targeting supercharges always-on campaigns

See how we helped a client adapt to anticipated competitive pressures and sales rep vacancies in key regions, maximizing HCP engagement by intelligently layering hyper-targeted tactics onto their existing always-on foundation.

Optichannel excellence, Patient engagement, Product lifecycle, Real-world data

Strategic advantage: Optichannel engagement drives ROI across the product lifecycle

This article in Pharmaceutical Executive explores how optichannel strategies bridge personal and nonpersonal efforts from early pre-launch planning through brand growth.

Life science trends, News

PharmaForceIQ Announces Substantial Growth as It Expands Optichannel Engagement Solutions

PharmaForceIQ, a fast-growing provider of precision customer engagement technologies, announces a period of accelerated growth marked by a transformative shift toward optichannel marketing. The company has seen a multifold increase in average contract value and achieved a 100% client renewal rate—underscoring the measurable impact of its advanced, data-driven strategies.

Audience insights, Optichannel excellence

PM360: The Efficiency Trifecta: Keys to Maximizing Pharma Marketing ROI

Hemal Somaiya shares insights in PM360 on how agile pharma marketing strategies, real-time data, and AI-powered precision are transforming ROI for marketers.

Life science trends, News, Optichannel excellence

PharmaForceIQ’s Hemal Somaiya Honored as a ‘Disrupter’ in the 2025 PM360 ELITE 100 Awards

Chief Strategy Officer, Hemal Somaiya, has been selected by PM360 as an honoree in the ‘Disrupter’ category of the 2025 PM360 ELITE 100 program.

Life science trends, News, Optichannel excellence

PharmaForceIQ’s Hemal Somaiya Recognized As One Of MM+M’s ‘Women Of Distinction’ For 2025

PharmaForceIQ is pleased to announce that executive Hemal Somaiya has been selected by MM+M as an honoree in the 2025 Women of Distinction program.

Life science trends, News

PharmaForceIQ Announces Majority Investment by Eir Partners to Support and Accelerate Growth

Medical and Clinical teams today announced a significant investment by Eir Partners (Eir) to accelerate adoption of the company’s unique technology platform and services for the Life Science industry.